Use of preferentially replicating bacteria for the treatment of cancer
J Clin Invest
.
2000 Apr;105(8):1027-30.
doi: 10.1172/JCI9818.
Authors
M Sznol
1
,
S L Lin
,
D Bermudes
,
L M Zheng
,
I King
Affiliation
1
Vion Pharmaceuticals Inc., New Haven, Connecticut 06511, USA. msznol@vionpharm.com
PMID:
10772643
PMCID:
PMC300839
DOI:
10.1172/JCI9818
No abstract available
Publication types
Review
MeSH terms
Animals
Biological Therapy
Cell Division
Genetic Engineering
Humans
Neoplasms / therapy*
Salmonella / genetics
Salmonella / physiology*